Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease
- PMID: 1999069
- DOI: 10.1016/s0009-9260(05)80350-2
Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease
Abstract
To establish the accuracy of ultrasonography in assessing diffuse parenchymal liver disease we performed a prospective comparative study with histology in 50 patients with a wide range of liver disease. Liver biopsy was performed within 24 h of the ultrasound examination and ultrasonography was performed by a single operator who was unaware of clinical details of the patients. Histology was reviewed blind and the degree of steatosis graded mild, moderate or severe while increased portal fibrous tissue was graded mild, moderate or established cirrhosis. Thirty-six patients had steatosis and 31 patients had increased fibrous tissue on histology. Ultrasonography correctly identified steatosis in 32/36 (89%) patients including all patients with the severe grade. Increased fibrous tissue was correctly identified in 24/31 (77%) with a sensitivity of 100% in patients with moderate fibrosis and established cirrhosis. Specificity was 93% for steatosis and 89% for increased fibrous tissue. These results show that ultrasonography can provide a non-invasive prediction of liver histology which in moderate and severe steatosis and advanced fibrosis can be both highly sensitive and specific.
Similar articles
-
[Accuracy of sonography in the diagnosis of diffuse liver parenchymal diseases--comparison of sonography and liver histology].Ultraschall Med. 1984 Jun;5(3):98-103. doi: 10.1055/s-2007-1012076. Ultraschall Med. 1984. PMID: 6474150 German.
-
Noninvasive assessment of liver steatosis, fibrosis and inflammation in chronic hepatitis C virus infection.Liver Int. 2005 Dec;25(6):1150-5. doi: 10.1111/j.1478-3231.2005.01164.x. Liver Int. 2005. PMID: 16343065
-
[Echomorphological comparisons in chronic diseases of the liver].Ter Arkh. 1989;61(2):52-5. Ter Arkh. 1989. PMID: 2658194 Russian.
-
[Current trends in liver biopsy indications in chronic liver diseases].Presse Med. 2012 Nov;41(11):1064-70. doi: 10.1016/j.lpm.2012.01.034. Epub 2012 Mar 15. Presse Med. 2012. PMID: 22425478 Review. French.
-
CT and MRI of diffuse liver disease.Semin Ultrasound CT MR. 1995 Feb;16(1):16-33. doi: 10.1016/0887-2171(95)90012-8. Semin Ultrasound CT MR. 1995. PMID: 7718279 Review.
Cited by
-
Epidemiological, clinical, and biochemical characteristics of Saudi patients with nonalcoholic fatty liver disease: a hospital-based study.Ann Saudi Med. 2012 May-Jun;32(3):288-92. doi: 10.5144/0256-4947.2012.288. Ann Saudi Med. 2012. PMID: 22588441 Free PMC article.
-
Hyperinsulinemia predisposes to NAFLD.Indian J Clin Biochem. 2008 Apr;23(2):130-5. doi: 10.1007/s12291-008-0030-6. Epub 2008 Jun 11. Indian J Clin Biochem. 2008. PMID: 23105738 Free PMC article.
-
Nonalcoholic fatty liver disease in a district general hospital: clinical presentation and risk factors.Hepatol Int. 2008 Jun;2(2):190-5. doi: 10.1007/s12072-008-9044-7. Epub 2008 Feb 28. Hepatol Int. 2008. PMID: 19669303 Free PMC article.
-
The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents.Metabolites. 2022 Feb 8;12(2):155. doi: 10.3390/metabo12020155. Metabolites. 2022. PMID: 35208229 Free PMC article.
-
Development of colorectal cancer predicts increased risk of subsequent hepatocellular carcinoma in patients with alcoholic liver disease: case-control and cohort study.Sci Rep. 2019 Mar 1;9(1):3236. doi: 10.1038/s41598-019-39573-9. Sci Rep. 2019. PMID: 30824851 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical